KM

Krishna Moorthy Chandru

Active Director Director DIN 00893481
DIN 00893481 First appointment Mar 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Mar 2004
Shareholding value •••• Premium profile

About Krishna Moorthy Chandru

Data last updated:

Krishna Moorthy Chandru is a Director at M Sea Pharmaceuticals Private Limited (since 2015), Director at Rp Lifesciences Private Limited (since 2024) and Director at Enerbay Lifesciences Private Limited (since 2023). The companies operate in Pharma, Recycling & Waste Management and Paper. The largest current company by reported revenue is M Sea Pharmaceuticals Private Limited at ₹13.67 Cr (FY 2024). Earlier, Krishna Moorthy Chandru was a Director at Reddy Life Sciences Private Limited (2007–2018) and Director at Reo Remedies Private Limited (2004–2018) and 3 more.

DIN 00893481
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2004
Oldest Company Age 18 yrs
Largest company M Sea Pharmaceuticals Private Limited · ₹13.67 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20152015₹13.67 Cr (FY 2024)Active
Rp Lifesciences Private Limited U90000UP2024PTC209189
Director10 Sep 20242024Active
Enerbay Lifesciences Private Limited U21002UP2023FTC179024
Director27 Mar 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Reddy Life Sciences Private Limited U24239TS2003PTC206754
Director09 Apr 20072003₹46,958 (FY 2016)Active
Reo Remedies Private Limited U24239TS2004PTC206753
Director08 Mar 20042004Active
Ckg Life Sciences Private Limited U74899DL2005PTC143069
Director29 Nov 20052005₹2.62 Cr (FY 2018)Active
Reddy Biotec Limited U24239TS2003PLC206755
Director09 Apr 20072003Active
Ckg Holidays Private Limited U60200DL2008PTC180991
Director17 Jul 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Enerbay Lifesciences Private Limited
Ckg Holidays Private Limited
M Sea Pharmaceuticals Private Limited
Rp Lifesciences Private Limited
Premium access

Shareholding and investment profile for Krishna Moorthy Chandru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Moorthy Chandru

Krishna Moorthy Chandru currently holds 3 directorships: M Sea Pharmaceuticals Private Limited (Director, since 01 Apr 2015, revenue ₹13.67 Cr (FY 2024)); Rp Lifesciences Private Limited (Director, since 10 Sep 2024); Enerbay Lifesciences Private Limited (Director, since 27 Mar 2023).

Krishna Moorthy Chandru was first appointed on 08 Mar 2004 as Director at Reo Remedies Private Limited. The most recent appointment on record is 10 Sep 2024 at Rp Lifesciences Private Limited.

Krishna Moorthy Chandru held 5 earlier board appointments: Reddy Life Sciences Private Limited (Director, 09 Apr 2007 to 29 Mar 2018); Reo Remedies Private Limited (Director, 08 Mar 2004 to 29 Mar 2018); Ckg Life Sciences Private Limited (Director, 29 Nov 2005 to 05 Mar 2022); Reddy Biotec Limited (Director, 09 Apr 2007 to 29 Mar 2018); Ckg Holidays Private Limited (Director, from 17 Jul 2008).

The current boards of Krishna Moorthy Chandru's companies include Ajay Agarwal (M Sea Pharmaceuticals Private Limited), Harinath Harinath (M Sea Pharmaceuticals Private Limited), Manish Agarwal (M Sea Pharmaceuticals Private Limited), Selvaraj Santha Kumar (M Sea Pharmaceuticals Private Limited), Shailender Kumar (M Sea Pharmaceuticals Private Limited), Rajeev Kumar Pathak (Rp Lifesciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available